AcquisitionOther
Paratek Pharmaceuticals, Inc. acquired OptiNose, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Paratek Pharmaceuticals, Inc. -> OptiNose, Inc. · $330 million
Adding XHANCE to our portfolio to become a multi-product specialty therapeutics company focused on addressing unmet medical needs
Open source record (SEC) ↗